Anti-STIM1/ D11S4896E/ GOK monoclonal antibody

Anti-STIM1/ D11S4896E/ GOK antibody for FACS & in-vivo assay

Target products collectionGo to STIM1/STIM1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1716-Ab-1/ GM-Tg-hg-MP1716-Ab-2Anti-Human STIM1 monoclonal antibodyHuman
GM-Tg-rg-MP1716-Ab-1/ GM-Tg-rg-MP1716-Ab-2Anti-Rat STIM1 monoclonal antibodyRat
GM-Tg-mg-MP1716-Ab-1/ GM-Tg-mg-MP1716-Ab-2Anti-Mouse STIM1 monoclonal antibodyMouse
GM-Tg-cynog-MP1716-Ab-1/ GM-Tg-cynog-MP1716-Ab-2Anti-Cynomolgus/ Rhesus macaque STIM1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1716-Ab-1/ GM-Tg-felg-MP1716-Ab-2Anti-Feline STIM1 monoclonal antibodyFeline
GM-Tg-cang-MP1716-Ab-1/ GM-Tg-cang-MP1716-Ab-2Anti-Canine STIM1 monoclonal antibodyCanine
GM-Tg-bovg-MP1716-Ab-1/ GM-Tg-bovg-MP1716-Ab-2Anti-Bovine STIM1 monoclonal antibodyBovine
GM-Tg-equg-MP1716-Ab-1/ GM-Tg-equg-MP1716-Ab-2Anti-Equine STIM1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1716-Ab-1/ GM-Tg-hg-MP1716-Ab-2; GM-Tg-rg-MP1716-Ab-1/ GM-Tg-rg-MP1716-Ab-2;
GM-Tg-mg-MP1716-Ab-1/ GM-Tg-mg-MP1716-Ab-2; GM-Tg-cynog-MP1716-Ab-1/ GM-Tg-cynog-MP1716-Ab-2;
GM-Tg-felg-MP1716-Ab-1/ GM-Tg-felg-MP1716-Ab-2; GM-Tg-cang-MP1716-Ab-1/ GM-Tg-cang-MP1716-Ab-2;
GM-Tg-bovg-MP1716-Ab-1/ GM-Tg-bovg-MP1716-Ab-2; GM-Tg-equg-MP1716-Ab-1/ GM-Tg-equg-MP1716-Ab-2
Products NameAnti-STIM1 monoclonal antibody
Formatmab
Target NameSTIM1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-STIM1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species STIM1/ D11S4896E/ GOK VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP001315human STIM1 Lentivirus particle
    ORF Viral VectorpGMLP001315human STIM1 Lentivirus plasmid
    ORF Viral VectorpGMAD000647Norway rat Stim1 Adenovirus plasmid
    ORF Viral VectorpGMLPm004111mouse Stim1 Lentivirus plasmid
    ORF Viral VectorvGMAD000647Norway rat Stim1 Adenovirus particle
    ORF Viral VectorvGMLPm004111mouse Stim1 Lentivirus particle


    Target information

    Target IDGM-MP1716
    Target NameSTIM1
    Gene ID6786,20866,361618,717963,608643,101087780,534816,100053079
    Gene Symbol and SynonymsD11S4896E,GOK,IMD10,SIM,STIM1,STRMK,TAM,TAM1
    Uniprot AccessionQ13586,P84903,Q58CP9
    Uniprot Entry NameSTIM1_HUMAN,STIM1_RAT,STIM1_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000167323
    Target ClassificationTumor-associated antigen (TAA)

    The target: STIM1, gene name: STIM1, also named as D11S4896E, GOK, IMD10, STRMK, TAM, TAM1. This gene encodes a type 1 transmembrane protein that mediates Ca2+ influx after depletion of intracellular Ca2+ stores by gating of store-operated Ca2+ influx channels (SOCs). It is one of several genes located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocrotical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region, as well as early hematopoiesis, by mediating attachment to stromal cells. Mutations in this gene are associated with fatal classic Kaposi sarcoma, immunodeficiency due to defects in store-operated calcium entry (SOCE) in fibroblasts, ectodermal dysplasia and tubular aggregate myopathy. This gene is oriented in a head-to-tail configuration with the ribonucleotide reductase 1 gene (RRM1), with the 3' end of this gene situated 1.6 kb from the 5' end of the RRM1 gene. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.